Table 2.
Medical morbidities and developmental outcomes of infants with and without LVCP1
| LVCP1 n (%) |
No LVCP1 n (%) |
P | |
|---|---|---|---|
| Respiratory Outcomes | |||
| Reactive airway disease | 19 (86) | 11 (33) | <0.0001 |
| Bronchopulmonary dysplasia | 18 (82) | 13 (39) | 0.002 |
| Total days of mechanical ventilation2 | 44 ± 24 | 29 ± 16 | 0.008 |
| Aspiration | 17 (77) | 1 (33) | 0.18 |
| Feeding and Growth Outcomes | |||
| Gastrostomy tube insertion | 14 (64) | 2 (6) | <0.0001 |
| Nissen fundoplication | 9 (41) | 1 (3) | 0.001 |
| Need for GER3 medications at discharge | 12 (55) | 13 (42) | 0.41 |
| Weight at 18-22 months CGA4 <10th %ile | 12 (63) | 8 (36) | 0.12 |
| Length at 18-22 months CGA4 <10th %ile | 9 (47) | 7 (32) | 0.35 |
| HC5 at 18-22 months CGA4 <10th %ile | 12 (63) | 15 (68) | 0.75 |
| Neurodevelopmental Outcomes | |||
| MDI6<70 | 5 (33) | 7 (36) | 0.99 |
| PDI7<70 | 8 (53) | 6 (32) | 0.26 |
| Neurodevelopmental impairment8 | 10 (56) | 8 (36) | 0.34 |
1
Left vocal cord paralysis
2
Values are mean ± SD
3
Gastroesophageal reflux
4
Corrected gestational age
5
Head circumference
6
Mental Development Index
7
Psychomotor Development Index
8
Defined as MDI or PDI <70 on Bayley Scales of Infant Development